byl719 and Colitis

byl719 has been researched along with Colitis* in 1 studies

1 other study(ies) available for byl719 and Colitis

Article	Year
Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration. JAMA oncology, 2022, 10-01, Volume: 8, Issue:10 This case series investigates reports of 20 patients with colitis temporally associated with alpelisib use. Topics: Antineoplastic Combined Chemotherapy Protocols; Colitis; Humans; Thiazoles; United States; United States Food and Drug Administration	2022

Article

Year

JAMA oncology, 2022, 10-01, Volume: 8, Issue:10

This case series investigates reports of 20 patients with colitis temporally associated with alpelisib use.

Topics: Antineoplastic Combined Chemotherapy Protocols; Colitis; Humans; Thiazoles; United States; United States Food and Drug Administration

2022